Share-based Payment Arrangement, Expense of Edesa Biotech, Inc. from 30 Sep 2023 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
- Summary
-
Edesa Biotech, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2023 to 31 Dec 2025.
- Edesa Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $400,000, a 400% increase year-over-year.
- Edesa Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $700,000, a 40% increase from 2024.
- Edesa Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $500,000, a 58% decline from 2023.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Edesa Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $400,000 | +$320,000 | +400% | 01 Oct 2025 | 31 Dec 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 | |
| Q2 2025 | $200,000 | +$100,000 | +100% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 08 Aug 2025 | 2025 | Q3 | |
| Q4 2024 | $80,000 | 01 Oct 2024 | 31 Dec 2024 | 10-Q | 13 Feb 2026 | 2026 | Q1 | |||
| Q2 2024 | $100,000 | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 08 Aug 2025 | 2025 | Q3 |
Edesa Biotech, Inc. Annual Share-based Payment Arrangement, Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $700,000 | +$200,000 | +40% | 01 Oct 2024 | 30 Sep 2025 | 10-K | 12 Dec 2025 | 2025 | FY |
| 2024 | $500,000 | -$700,000 | -58% | 01 Oct 2023 | 30 Sep 2024 | 10-K | 12 Dec 2025 | 2025 | FY |
| 2023 | $1,200,000 | 01 Oct 2022 | 30 Sep 2023 | 10-K | 13 Dec 2024 | 2024 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.